# K2HPO4+KH2PO4

## Potassium Phosphate inj 20mL

| TAH Drug Code      | [IK2P](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IK2P)                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | For TPN preparation, Severe hypophosphataemia.                                                                                                                                                                                                                                                                                                                                                    |
| Dosing             | As TPN material only. Each mL contains: Potassium 4.4 mEq and phosphorus 3 mmol = potassium 170 mg and elemental phosphorus 93 mg. Dose and rate of administration are dependent on individual patient needs.                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Severe renal impairment, hyperkalaemia, hypocalcaemia, infected phosphate renal calculi.                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | Hyperphosphataemia esp in renal failure which may lead to hypocalcaemia and ectopic calcification esp in hypercalcaemic patients. Hypotension and organ damage due to tissue calcification which may cause acute renal failure. Hyperphosphataemia, hypocalcaemia, tissue calcification; nausea, vomiting, diarrhoea, abdominal pain, flatulence; bradycardia; hyperkalaemia; weakness; dyspnoea. |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                        |
| More Info          | [UpToDate](https://www.uptodate.com/contents/k2hpo4+kh2po4-drug-information)                                                                                                                                                                                                                                                                                                                      |

